Electrotransport drug delivery device having tactile signaling means

• US 6,175,763 B1
• Filed: 03/29/1996
• Issued: 01/16/2001
• Est. Priority Date: 03/29/1996
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: McNichols, Larry A., Sorenson, Paul D., Lattin, Gary A.
• Primary Examiner(s): Bockelman, Mark
• Application Number:
  US08/627,762
• Time in Patent Office: 1,754 Days
• Field of Search: 604/20-21, 604/501, 116/205, 116/DIG.27
• US Class Current: 604/20
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Abstract

An electrotransport system (20) for delivery of a drug through the skin (63) of a patient includes a tactile signal generator (36) for generating and transmitting a tactile signal to the skin of a patient upon the occurrence of an event associated with the operation of the system. The tactile signal may be an electric AC signaling current (Sr, Sp) applied through the skin, ie, an electric current different from the therapeutic electrotransport drive current. The electric signaling current is preferably a pulsed current of sufficient frequency and amplitude to allow the patient to feel it. The tactile signal may alternatively be generated by an electromechanical device in contact with the skin such as a piezoelectric vibrating element or magnetodynamic element such as a solenoid driven pin. The waveform of the tactile signaling current preferably has a zero average current component such that no net therapeutic drug is delivered by the tactile signal current. In certain cases, the tactile signaling current may contribute to electrotransport drug delivery.

Claims

1. An electrotransport drug delivery system which can signal, to a patient wearing the system, an occurrence of an event or condition associated with operation of the system, comprising:

an electrotransport drug delivery system including a pair of electrodes, at least one of which having a reservoir attached thereto, through which an electrotransport drug delivering current is applied to the patient;

a sensor connected to the system for sensing an event or condition associated with the operation of the system;

a tactile signal generator connected to the system, responsive to the sensor, for generating and transmitting an electric tactile signaling current through the pair of electrodes to the patient, the signaling current having a magnitude and waveform shape which is capable of being felt by the patient and which delivers little to no net drug to the patient.

2. The system of claim 1, including a controller, communicating with the sensor and the tactile signal generator, for controlling the signal generator to generate the tactile signal when the event or condition is sensed by the sensor.

3. The system of claim 1, wherein the sensor senses an event or condition selected from the group consisting of reservoir pH, skin resistance, battery voltage, applied electrotransport current, Ag+ ion concentration, hydronium (H+) ion concentration, hydroxyl (OH−

) ion concentration.

4. The system of claim 2, including a comparator for comparing the sensed event or condition with a predetermined value therefor.

5. The system of claim 1, wherein the event or condition comprises skin resistance and the sensor includes a resistance sensor for sensing voltage drop responsive to skin resistance across donor and counter electrodes.

6. The system of claim 1, wherein the event or condition comprises applied electrotransport current and the sensor includes an applied electrotransport current sensor.

7. The system of claim 1, wherein the sensor is capable of sensing a plurality of different types of events or conditions.

8. The system of claim 7, wherein the tactile signal generator is capable of generating and transmitting a plurality of different tactile signaling currents to the patient, each tactile signaling current corresponding to one of said plurality of different events or conditions.

9. The system of claim 1, wherein the electric tactile signaling current has a waveform which delivers drug to the patient by electrotransport.

10. The system of claim 1, wherein the electric tactile signaling current has alternating periods of different length.

11. The system of claim 1, wherein the electric tactile signaling current is an alternating current.

12. The system of claim 1, wherein the electric tactile signaling current has alternating periods of different frequency.

13. The system of claim 1, wherein the electric tactile signaling current has alternating periods of different amplitude.

14. The system of claim 1, wherein the electric tactile signaling current has a waveform which delivers substantially no drug to the patient by electrotransport.

15. A method for signaling a patient of an occurrence of an event or condition associated with operation of an electrotransport drug delivery system worn by the patient, the system including a pair of electrodes, at least one of which having a reservoir attached thereto, through which an electrotransport drug delivering current is applied to the patient, the method comprising:

sensing an event or condition associated with operation of the electrotransport drug delivery system;

generating an electric tactile signaling current in response to the sensed event or condition; and

transmitting the tactile signaling current to the patient through the pair of electrodes, the signaling current having a magnitude and waveform shape which is capable of being felt by the patient and which delivers little to no net drug to the patient.

16. The method of claim 15, wherein the sensed event or condition is selected from the group consisting of reservoir pH, skin resistance, battery voltage, and applied electrotransport current.

17. The method of claim 15, including comparing the sensed event or condition with a predetermined value therefor.

18. The method of claim 15, wherein the event or condition comprises skin resistance and the sensing comprises sensing voltage drop across donor and counter electrodes.

19. The method of claim 15, wherein the event or condition comprises applied electrotransport current.

20. The method of claim 15, including sensing a plurality of different types of events or conditions.

21. The method of claim 20, including generating and transmitting a plurality of different tactile signaling currents to the patient, each tactile signaling current corresponding to one of said plurality of different events or conditions.

22. The method of claim 15, wherein the tactile signaling current is an alternating current.

23. The method of claim 15, wherein the tactile signaling current has alternating periods of different length.

24. The method of claim 15, wherein the tactile signaling current has alternating periods of different frequency.

25. The method of claim 15, wherein the tactile signaling current has alternating periods of different amplitude.

26. The method of claim 15, wherein the tactile signaling current has a waveform which delivers substantially no drug to the patient by electrotransport.

27. The method of claim 15, wherein the tactile signaling current has a waveform which delivers drug to the patient by electrotransport.